Brierley, Daniel I. http://orcid.org/0000-0002-4360-2648
Holt, Marie K.
Singh, Arashdeep http://orcid.org/0000-0002-2477-1438
de Araujo, Alan http://orcid.org/0000-0003-2656-4077
McDougle, Molly
Vergara, Macarena http://orcid.org/0000-0003-3823-979X
Afaghani, Majd H. http://orcid.org/0000-0003-0408-5243
Lee, Shin Jae
Scott, Karen http://orcid.org/0000-0002-4133-423X
Maske, Calyn
Langhans, Wolfgang http://orcid.org/0000-0001-9742-0068
Krause, Eric http://orcid.org/0000-0002-2718-3113
de Kloet, Annette
Gribble, Fiona M. http://orcid.org/0000-0002-4232-2898
Reimann, Frank http://orcid.org/0000-0001-9399-6377
Rinaman, Linda http://orcid.org/0000-0001-5999-8811
de Lartigue, Guillaume http://orcid.org/0000-0002-0032-8810
Trapp, Stefan http://orcid.org/0000-0003-0665-4948
Funding for this research was provided by:
Wellcome Trust (106262/Z/14/Z, 106263/Z/14/Z)
RCUK | Medical Research Council (MRC_MC_UU_12012/3, MR/N02589X/1)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK100685, R01 DK116004)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH059911)
Article History
Received: 4 August 2020
Accepted: 13 January 2021
First Online: 15 February 2021
Competing interests
: The F.R. and F.M.G. laboratory receives funding from AstraZeneca, Eli Lilly and LGM for unrelated research and F.M.G. consults for Kallyope (New York). All other authors have no competing interests to declare.